Article History
Accepted: 11 May 2022
First Online: 25 May 2022
Compliance with Ethical Standards
:
: Dr. LeWinter is a paid consultant for Kiniksa Pharmaceuticals. The other authors declare that they have no conflict of interest.
: Dr. LeWinter was an investigator for the Phase 3 Trial of Rilonacept (RHAPSODY; reference #27).
Free to read: This content has been made available to all.